Literature DB >> 12920638

Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula?

Guido Filler1, Nathalie Lepage.   

Abstract

It is common practice to estimate glomerular filtration rate (GFR) from the Schwartz formula (a height creatinine/ratio), although it has its limitations. Cystatin C was found to be a superior marker of GFR. No formula has been validated to estimate GFR from cystatin C in children. Children (aged 1.0-18 years, n=536) with various renal pathologies undergoing nuclear medicine GFR clearance studies ((99m)Tc-DTPA single-injection technique) were tested. Cystatin C was measured with a nephelometric assay. The Schwartz GFR was calculated using enzymatically determined serum creatinine in micromoles per liter using the constant 48 for adolescent males and 38 otherwise. Using multiple stepwise regression analysis on log/log-transformed data, we derived the following relationship between the cystatin C concentration and GFR:. Using the Bland and Altman analysis to test agreement between the Schwartz formula and gold standard GFR showed considerable bias, with a mean difference of +10.8% and a trend towards overestimation of the GFR by the Schwartz formula with lower GFRs. In contrast, the Bland and Altman analysis applied on the GFR estimate derived from cystatin C showed the mean difference to be negligible at +0.3% and no trend towards overestimation of the GFR with lower GFRs. In the regression analysis of the estimate and the GFR, the Schwartz estimate showed significant deviation from linearity, whereas the cystatin C estimate did not. In conclusion, the data suggest that this novel cystatin C-based GFR estimate shows significantly less bias and serves as a better estimate for GFR in children.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12920638     DOI: 10.1007/s00467-003-1271-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  15 in total

1.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Authors:  G J Schwartz; G B Haycock; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

2.  Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II).

Authors:  H Finney; D J Newman; W Gruber; P Merle; C P Price
Journal:  Clin Chem       Date:  1997-06       Impact factor: 8.327

3.  Limitations to body length/serum creatinine ratio as an estimate of glomerular filtration in children.

Authors:  M G Seikaly; R Browne; G Bajaj; B S Arant
Journal:  Pediatr Nephrol       Date:  1996-12       Impact factor: 3.714

4.  Cystatin C--a new marker of glomerular filtration rate in children independent of age and height.

Authors:  A Bökenkamp; M Domanetzki; R Zinck; G Schumann; D Byrd; J Brodehl
Journal:  Pediatrics       Date:  1998-05       Impact factor: 7.124

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  Serum alpha 1-microglobulin and beta 2-microglobulin for the estimation of fetal glomerular renal function.

Authors:  S Nolte; B Mueller; W Pringsheim
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

7.  Beta-trace protein, cystatin C, beta(2)-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children.

Authors:  Guido Filler; Friedrich Priem; Nathalie Lepage; Pranav Sinha; Ilka Vollmer; Heather Clark; Erin Keely; Mary Matzinger; Ayub Akbari; Harald Althaus; Klaus Jung
Journal:  Clin Chem       Date:  2002-05       Impact factor: 8.327

8.  Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis.

Authors:  Vikas R Dharnidharka; Charles Kwon; Gary Stevens
Journal:  Am J Kidney Dis       Date:  2002-08       Impact factor: 8.860

9.  Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System.

Authors:  E J Erlandsen; E Randers; J H Kristensen
Journal:  Scand J Clin Lab Invest       Date:  1999-02       Impact factor: 1.713

10.  Optimum sample times for single-injection, multisample renal clearance methods.

Authors:  C D Russell
Journal:  J Nucl Med       Date:  1993-10       Impact factor: 10.057

View more
  119 in total

1.  Updated height- and creatinine-based equation and its validation for estimation of glomerular filtration rate in children from developing countries.

Authors:  Pankaj Hari; Bivas Biswas; Ravindra Pandey; Mani Kalaivani; Rakesh Kumar; Arvind Bagga
Journal:  Clin Exp Nephrol       Date:  2012-04-21       Impact factor: 2.801

2.  High prevalence of elevated lead levels in pediatric dialysis patients.

Authors:  Guido Filler; Elizabeth Roach; Abeer Yasin; Ajay P Sharma; Peter G Blake; Liju Yang
Journal:  Pediatr Nephrol       Date:  2012-04-17       Impact factor: 3.714

3.  Left ventricular mass and systolic function in children with chronic kidney disease-comparing echocardiography with cardiac magnetic resonance imaging.

Authors:  Raoul Arnold; Daniel Schwendinger; Sabine Jung; Martin Pohl; Bernd Jung; Julia Geiger; Charlotte Gimpel
Journal:  Pediatr Nephrol       Date:  2015-09-05       Impact factor: 3.714

4.  Cystatin C: our experience.

Authors:  Snezana Pavićević; Amira Peco-Antić
Journal:  Pediatr Nephrol       Date:  2005-06       Impact factor: 3.714

5.  Medication errors and patient complications with continuous renal replacement therapy.

Authors:  Jeffrey F Barletta; Gina-Marie Barletta; Patrick D Brophy; Norma J Maxvold; Richard M Hackbarth; Timothy E Bunchman
Journal:  Pediatr Nephrol       Date:  2006-04-19       Impact factor: 3.714

Review 6.  Diuretics in pediatrics : current knowledge and future prospects.

Authors:  Maria M J van der Vorst; Joana E Kist; Albert J van der Heijden; Jacobus Burggraaf
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

7.  Pharmacokinetic properties of conventional and double-dose sulfadoxine-pyrimethamine given as intermittent preventive treatment in infancy.

Authors:  Sam Salman; Susan Griffin; Kay Kose; Nolene Pitus; Josephine Winmai; Brioni Moore; Peter Siba; Kenneth F Ilett; Ivo Mueller; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

8.  Impact of urine concentration adjustment method on associations between urine metals and estimated glomerular filtration rates (eGFR) in adolescents.

Authors:  Virginia M Weaver; Gonzalo García Vargas; Ellen K Silbergeld; Stephen J Rothenberg; Jeffrey J Fadrowski; Marisela Rubio-Andrade; Patrick J Parsons; Amy J Steuerwald; Ana Navas-Acien; Eliseo Guallar
Journal:  Environ Res       Date:  2014-05-08       Impact factor: 6.498

9.  Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease.

Authors:  Mark M Mitsnefes; Thelma S Kathman; Jaya Mishra; Janis Kartal; Philip R Khoury; Thomas L Nickolas; Jonathan Barasch; Prasad Devarajan
Journal:  Pediatr Nephrol       Date:  2006-10-27       Impact factor: 3.714

10.  Nephrological and urological complications of homozygous c.974G>A (p.Arg325Gln) OSGEP mutations.

Authors:  Peter Zhan Tao Wang; Chitra Prasad; Carmen Inés Rodriguez Cuellar; Guido Filler
Journal:  Pediatr Nephrol       Date:  2018-08-23       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.